Blake Aftab
2022
In 2022, Blake Aftab earned a total compensation of $2.5M as Chief Scientific Officer at Adicet Bio.
Compensation breakdown
| Non-Equity Incentive Plan | $182,600 |
|---|---|
| Option Awards | $1,804,505 |
| Salary | $401,769 |
| Other | $90,670 |
| Total | $2,479,544 |
Aftab received $1.8M in option awards, accounting for 73% of the total pay in 2022.
Aftab also received $182.6K in non-equity incentive plan, $401.8K in salary and $90.7K in other compensation.
Rankings
In 2022, Blake Aftab's compensation ranked 1,464th out of 5,744 executives tracked by ExecPay. In other words, Aftab earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,464 out of 5,744 | 75th |
Division Manufacturing | 734 out of 3,128 | 77th |
Major group Chemicals And Allied Products | 285 out of 1,416 | 80th |
Industry group Drugs | 264 out of 1,317 | 80th |
Industry Pharmaceutical Preparations | 187 out of 963 | 81st |
Source: SEC filing on April 18, 2023.
Aftab's colleagues
We found two more compensation records of executives who worked with Blake Aftab at Adicet Bio in 2022.